Beranda › Depresi › New York › New York City
Uji klinis Depresi di New York City, NY
45 studi untuk Depresi mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Menerima pesertaFase 3
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Menerima pesertaFase 3
- Adams Clinical Harlem, New York
Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)
Menerima peserta
- NYU Langone Health, New York
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 2
- Ima Clinical Research - Nyc Midtown, New York
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Menerima peserta
- New York Presbyterian Hospital/Weill Cornell Medicine, New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- NYU Langone Health, New York
Psilocybin as a Novel Therapy for Residual Anhedonia
Menerima pesertaFase 1
- NYU Langone Health, New York
Pattern Separation in Major Depressive Disorder
Menerima pesertaFase 1
- New York State Psychiatric Institute (NYSPI), New York
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Menerima pesertaFase 2
- Seaport Investigator Site, New York
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Menerima pesertaFase 3
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Menerima pesertaFase 2
- Draig Clinical Site, New York
- Draig Clinical Site, New York
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Menerima pesertaFase 2
- Draig Clinical Site, New York
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction
Menerima pesertaFase 2
- Weill Cornell Medical Center, New York
Improving the Mental Health of Home Health Aides
Menerima pesertaSukarelawan sehat diterima
- 1199 SEIU Home Care Industry Education Fund, New York
- Weill Cornell Medicine, New York
Psilocybin-Assisted Therapy for Intergenerational Trauma
Menerima pesertaFase 2
- The Parsons Research Center for Psychedelic Healing, New York
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, New York
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, New York
Mobile Cognitive Behavioral Therapy for Stroke
Menerima peserta
- Weill Cornell Medicine, New York
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Mount Sinai West, New York
- dan 1 lainnya
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
Menerima peserta
- Weill Cornell Medicine, New York
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
Sleep More, Stress Less: 90-Day Trial of Neuralli Mood
Menerima pesertaSukarelawan sehat diterima
- Efforia - Decentralized United States Study, New York
Assessment of Music Experiences in Navigating Depression Part 2
Menerima peserta
- Mount Sinai Union Square, New York
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
Menerima pesertaFase 2
- NYU Langone Health, New York
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
Menerima peserta
- NYU Langone Health, New York
Virtual Reality for Pain Management in Burn Patients
Menerima peserta
- Weill Cornell Medicine, New York
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Menerima peserta
- Icahn School of Medicine at Mount Sinai, New York
WeCare: A System of Care for Black Youth
Menerima pesertaSukarelawan sehat diterima
- Kings County Hospital, New York
tDCS: Sleep to Mood in Depression (S2M-D)
Menerima peserta
- NYU Langone Health, New York
Personalized Mobile Cognitive Behavioral Therapy Application
Menerima peserta
- Weill Cornell Medical College, New York
Mobile CBT for Middle Aged and Older Adults
Menerima peserta
- Weill Cornell Medicine, New York
Harlem Strong Mental Health Coalition
Menerima pesertaSukarelawan sehat diterima
- CUNY Graduate School of Public Health and Health Policy, New York
- Harlem Congregation for Community Improvement, New York
Prevention of Psychological Health Problems Via Integrated Operational Support
Menerima pesertaSukarelawan sehat diterima
- New York University, New York
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Menerima pesertaFase 2
- The Medical Research Network, LLC, New York
Safe Mothers, Safe Children Initiative
Menerima peserta
- McSilver Institute for Poverty Policy and Research, New York
Neutralizing Interleukin (IL)-6
Menerima pesertaFase 2Sukarelawan sehat diterima
- Icahn School of Medicine at Mount Sinai, New York
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
Menerima peserta
- Weill Cornell Medicine, New York
Readiness and Progress in Emotion Regulation Therapy
Menerima peserta
- Teachers College, Columbia University, New York
A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients
Menerima peserta
- Columbia University Irving Medical Center, New York
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
Menerima peserta
- Columbia University, New York
Telephone-Based Support Programs for People With Epilepsy
Menerima peserta
- NYU Langone Health, New York
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Menerima pesertaFase 4
- Clinical Research Site, New York
Brief Interventions for Coping with Distress
Menerima peserta
- Teachers College, Columbia University, New York
Lay-Delivered Behavioral Activation in Senior Centers
Menerima peserta
- Hudson Guild Senior Center, New York
- Lincoln Square Senior Center, New York
- Goddard Riverside Community Center and NORC, New York
- dan 3 lainnya
An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression
Menerima pesertaStudi observasional
- Singula Institute, 353 Lexington Avenue (Room 600), New York
Uji klinis Depresi di kota lain
- Boston, MA52 studi
- Philadelphia, PA26 studi
- Atlanta, GA24 studi
- Chicago, IL24 studi
- Pittsburgh, PA22 studi
- San Diego, CA21 studi
- Charleston, SC19 studi
- Los Angeles, CA17 studi
- Houston, TX17 studi
- Orlando, FL17 studi
- Miami, FL16 studi
- San Francisco, CA15 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.